Introduction
============

Synaptic plasticity in the hippocampus is a prominent cellular model of learning and memory ([@b16]). Information flows unidirectionally through the hippocampus, entering via the dentate gyrus (DG), before reaching CA3 and finally CA1 (this last synapse is called the Schaffer Collateral). In slices, specific patterns of stimulation to the Schaffer Collateral can induce long-lasting increases and decreases in synaptic strength, termed long-term potentiation (LTP) and depression (LTD) respectively.

The cell signalling underlying LTP at Schaffer Collateral synapses has been intensively studied, and a multitude of signalling molecules have been identified ([@b47]). Signalling for most forms of LTP starts with the flow of Ca^2+^ ions into postsynaptic sites through N-methyl-[d]{.smallcaps}-asparatic acid (NMDA)-type glutamate receptors (NMDAR) ([@b9]). At resting membrane potential, NMDARs are blocked by Mg^2+^ at the channel pore, but the Mg^2+^ block can be released by postsynaptic depolarization. Thus, NMDARs act as a coincidence detector for presynaptic glutamate release and postsynaptic depolarization ([@b9]). The Ca^2+^ elevation in spines activates numerous signalling proteins including protein kinase C (PKC), Ca^2+^/calmodulin-dependent kinase II (CaMKII) and small GTPase proteins such as Ras and Rho ([@b47]). These molecules lead to cellular processes important for LTP and LTD such as actin polymerization and depolymerization, membrane trafficking and exocytosis and endocytosis of glutamate receptors ([@b49]; [@b39]). The end result of these processes is an increase in synaptic strength, which for Schaffer Collateral LTP is achieved by the insertion of 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid (AMPA)-type glutamate receptors (AMPAR) into the synapse ([@b16]). It has also been reported that retrograde signalling from the post-synapse to the pre-synapse can occur, increasing the probability of presynaptic transmitter release ([@b62]; [@b19]).

In the hippocampus, most excitatory postsynaptic terminals reside in dendritic spines, small (∼0.1 fL) mushroom-shaped structures emanating from dendrites. Many spines are connected to the dendrite via a narrow neck that acts as a diffusion barrier to compartmentalize signalling in spines ([@b101]; [@b35]; [@b10]). Spine volume is tightly coupled with function: larger spines have a wider postsynaptic density, more functional AMPARs, and likely produce larger excitatory postsynaptic potential ([@b30]; [@b72]; [@b44]). The structure of spines is dynamically regulated in an activity-dependent manner ([@b44]). LTP and LTD are associated with long-term enlargement ([@b73]; [@b78]; [@b83]) and shrinkage ([@b119]) of dendritic spines respectively. Also, the spine neck resistance has been found to be regulated in an activity-dependent manner ([@b10]; [@b28]; [@b104]). In addition to modification of existing spines, new spine formation is associated with some forms of LTP ([@b17]; [@b70]; [@b107]). These diverse forms of structural plasticity may be important for regulating spine function and synaptic plasticity.

Recent advances in two-photon imaging and photochemistry now enable one to image spine structural plasticity and the associated functional plasticity in brain slices ([@b72]; [@b73];). Furthermore, signal transduction and molecular dynamics during spine structural plasticity have been imaged using two-photon fluorescence resonance energy transfer (FRET) techniques ([@b115]; [@b116]; [@b32]; [@b56]). These new techniques have provided many insights into the mechanisms and roles of spine structural plasticity. Furthermore, by combining these imaging techniques with pharmacology, the signalling mechanisms underlying different steps of structural and functional plasticity of dendritic spines have been revealed.

Studying structural and functional plasticity of dendritic spines
=================================================================

To image structural plasticity of spines undergoing LTP or LTD, one must identify stimulated spines. This is not simple, because in a typical electrophysiology experiment, 10--100 synapses are activated among ∼10 000 spines. One can load a cell with Ca^2+^ indicator and find stimulated spines in response to synaptic stimulation ([@b68]; [@b119]; [@b19]), but this is technically challenging. Alternatively, assuming that LTP is associated with spine enlargement, one could search for spines enlarged in response to synaptic stimulation ([@b52]; [@b31]; [@b114]).

Because imaging spines during electrophysiological LTP is difficult, multiple techniques to chemically induce LTP in many spines have been developed. In slices, chemical LTP (cLTP) can be induced by bath application of forskolin, rolipram and picrotoxin in zero Mg^2+^ ([@b81]; [@b52]). In this cocktail, forskolin (an activator of adenylyl cyclase) and rolipram (phosphodiestratase inhibitor) increase cAMP in CA3 neurons (and other neurons), causing burst activity in Schaffer Collateral synapses onto CA1. Picrotoxin increases the overall circuit activity by blocking inhibitory synapses, and removing Mg^2+^ unblocks NMDA receptors. This cLTP protocol produces spine enlargements as well as increases in excitatory postsynaptic current (EPSC) ([@b81]; [@b52]; [@b53];). Another method for cLTP uses the potassium channel blocker tetraethylammonium (TEA), which depolarizes cells, increases circuit activity and produces NMDA receptor--independent LTP and spine structural plasticity ([@b3]; [@b38]; [@b29]). In dissociated neurons, bath application of glycine (which enhances NMDA receptor response) and bicuculline (a GABAA receptor inhibitor) produces spine enlargements and increase in miniature EPSC ([@b66]; [@b83]). Because cLTP protocols strongly stimulate most synapses, they probably trigger other cell mechanisms like homeostasis or cell death.

In contrast to cLTP, two-photon uncaging of caged glutamate allows one to stimulate a single targeted dendritic spine, thus eliminating the need to search for stimulated spines ([@b72]). Caged glutamate does not bind to glutamate receptors, but photostimulation removes the caging group, releasing glutamate and activating glutamate receptors. To stimulate a selected spine, one aims a two-photon laser (720 nm for MNI-L-caged glutamate) near the spine head and delivers a series of short pulses (ms), uncaging glutamate near the spine, and activating glutamate receptors in the spine. With this method, one can directly measure synaptic strength by measuring the uncaging-evoked EPSC (uEPSC) due to AMPAR activation. Typically, the laser intensity is adjusted so that uEPSCs under the basal condition are ∼10 pA, an amplitude similar to mini-EPSCs ([@b72]; [@b73]; [@b99]; [@b104]; [@b56]). Because stimulating with uncaging alone does not depolarize spines enough to release the Mg^2+^ block of NMDAR, inducing LTP requires either pairing with postsynaptic depolarization or the removal of Mg^2+^ from extracellular solution to remove the Mg^2+^ block ([@b73]; [@b99]; [@b104]; [@b56]). It should be noted that synaptic plasticity induced by two-photon glutamate uncaging may be different from that induced by presynaptic fibre stimulation, as Ca^2+^ increase in presynaptic sites maybe important for some forms of plasticity and may omit other neurotransmitters. Protocols for LTD induction using two-photon glutamate uncaging have not been found yet.

Pharmacology of spine structural plasticity and LTP
===================================================

Long-lasting synaptic plasticity and associated spine structural plasticity share pharmacological properties, which we will compare for individual signalling molecules. For example, both LTP and associated spine enlargement are sensitive to inhibitors of CaMKII and Ras--extracellular signal-regulated kinase (ERK) signalling ([@b73]; [@b31]; [@b56]; [@b84]) ([Figure 1](#fig01){ref-type="fig"}).Actin polymerization ([@b73]; [@b78]) and exocytosis of endosomes ([@b82]; [@b83]; [@b114]) are involved in both processes. Similarly, LTD and associated spine shrinkage are inhibited by activation of calcineurin ([@b119]). However, the pathways for LTD and spine shrinkage seem to branch from there ([@b119]), as protein phosphatase 1/2A blockers calyculin A and okadaic acid inhibit LTD but not spine shrinkage. Conversely, phosphorylation of cofilin is involved only in spine shrinkage, but not in LTD ([@b119]).

![Hypothetical signalling pathways. The inputs are NMDAR activation and depolarization, while the outputs are transient and sustained spine growth and LTP. The signalling pathways in between have been studied for both LTP and for structural plasticity.](bph0163-1626-f1){#fig01}

During LTP induced by 100 Hz tetanic electrical stimulation, or low-frequency two-photon glutamate uncaging in zero Mg^2+^, spines undergo enlargement in two distinct phases: first a transient phase which lasts 1--3 min and then a sustained plateau phase lasting more than one hour ([@b73]) ([Figure 2](#fig02){ref-type="fig"}). The amplitude of the sustained volume increase measured at 20--60 min is +50--100% ([@b31]; [@b73]; [@b56]), while that of the transient phase (as defined by the peak volume change minus the sustained volume change) is +100--300% ([@b31]; [@b73]; [@b56]) ([Figure 2](#fig02){ref-type="fig"}). The transient and sustained phases have different pharmacological properties.

![Pharmacological analysis of spine enlargement induced by 2-photon glutamate uncaging in zero Mg^2+^. A. Characteristic images of spine growth following 2-photon glutamate uncaging. Uncaging pulses were applied at 0.5 Hz for 1 min (30 pulses). B. Time course of spine structural plasticity. Incubation with either KN62 (10 µM) or U0126 (20 µM) partially blocked the sustained phase of structural plasticity. Incubation with the both KN62 and U0126 completely blocked sustained structural plasticity. C. Pharmacology of transient and sustained phases of structural plasticity. For signalling molecules each inhibitor affects, please refer to [Table 1](#tbl1){ref-type="table"}.Panels B and C are modified from [@b32].](bph0163-1626-f2){#fig02}

Other stimulus protocols, like pairing uncaging with depolarization (either step or spikes) or electrical theta-burst stimulation, lead to a rapid increase in spine size with negligible decay ([@b31]; [@b99]; [@b104]; [@b114]; [@b56]). While these responses do not appear to have distinguishable transient and sustained phases, pharmacological manipulation reveals that these phases are nonetheless distinct ([@b104]; [@b114]). In the following sections, we review pharmacological analyses of spine structural plasticity associated with LTP under various conditions ([Figure 1](#fig01){ref-type="fig"}).

CaMKII
------

CaMKII is one of the most studied proteins involved in LTP and memory ([@b63]). CaMKII subunits combine into a dodecamer wherein each subunit acts as a serine--threonine kinase ([@b88]). When Ca^2+^ enters spines through NMDARs, Ca^2+^ binds to calmodulin, which in turn binds to CaMKII ([@b63]). Active CaMKII subunits autophosphorylate the T286 site of adjacent subunits, thus allowing the enzyme to remain active even after Ca^2+^/CaM dissociation. The importance of T286 phosphorylation in LTP, learning and memory has been demonstrated by mutating this autophosphorylation site to alanine (T286A) in mice; these animals have impaired LTP and perform poorly in a Morris Water maze ([@b26]). CaMKII\'s kinase activity is also important, as mice with a kinase-dead mutation in CaMKIIα (K42R) have impaired LTP and memory ([@b113]). Furthermore, various pharmacological inhibitors for CaMKII have been developed with different mechanisms, and they all consistently inhibit the induction of LTP ([@b71]; [@b42]; [@b41]; [@b80]; [@b11]). When constitutively active CaMKII is injected or expressed in neurons, synaptic strength is potentiated, showing CaMKII activation is sufficient to induce LTP ([@b64]; [@b34]).

The role of CaMKII in spine structural plasticity has also been extensively studied. KN62 and KN93, small molecule inhibitors of Ca^2+^-calmodulin kinases (CaMKs: they inhibit CaMKI, II, IV and CaMK kinase; [@b111]) inhibit the sustained phase of structural plasticity induced by 2-photon glutamate uncaging, but not the transient phase ([@b73]; [@b32]; [@b99]; [@b56]). Some studies show almost complete inhibition of the sustained phase ([@b73]; [@b99]), while others show only partial inhibition (∼50%) ([@b32]; [@b56]) ([Table 1](#tbl1){ref-type="table"}). Overexpression of mutant CaMKIIα (T286A) or autocamtide 2 CaMKII inhibitory peptide (AIP2) inhibits the sustained phase of structural plasticity ([@b56]; [@b77]). Also, mice with the kinase-dead mutation in CaMKIIα (K42R) exhibited deficits in sustained spine enlargement as well as in LTP ([@b113]).

###### 

The pharmacology and genetics of structural plasticity

  **Target**                                                     **Drug (concentration) or gene manipulation**                                               **Transient phase block**   **Sustained phase block**
  -------------------------------------------------------------- ------------------------------------------------------------------------------------------- --------------------------- ---------------------------
  Two-photon glutamate uncaging in 0 Mg^2+^                                                                                                                                              
  NMDAR                                                          AP5 (50 µM)[1](#tf1-1){ref-type="table-fn"}                                                 \+                          \+
                                                                 CPP (10 µM)[2](#tf1-2){ref-type="table-fn"}                                                 \+                          \+
  mGluR                                                          MCPG (0.5--1 mM)[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}           --                          --
  GluN2B                                                         Ifenprodil (3 µM)[2](#tf1-2){ref-type="table-fn"}                                           --                          --
  Calmodulin                                                     W7 (20 µM)[1](#tf1-1){ref-type="table-fn"}                                                  \+                          \+
                                                                 Calmidazolium(30 µM)[2](#tf1-2){ref-type="table-fn"}                                        Partial                     \+
  CaMKs                                                          KN62 (4 µM)[1](#tf1-1){ref-type="table-fn"}                                                 --                          \+
                                                                 KN62 (10 µM)[2](#tf1-2){ref-type="table-fn"},[3](#tf1-3){ref-type="table-fn"}               --                          Partial
                                                                 KN93 (10 µM)[4](#tf1-4){ref-type="table-fn"}                                                --                          \+
  CaMKII                                                         CaMKII(T286A)[3](#tf1-3){ref-type="table-fn"}                                               --                          Partial
                                                                 AIP2[5](#tf1-5){ref-type="table-fn"}                                                        --                          \+
  MEK                                                            U0126 (20 µM)[2](#tf1-2){ref-type="table-fn"}                                               --                          Partial
  Ras                                                            DN-Ras (S17N)[2](#tf1-2){ref-type="table-fn"}                                               --                          Partial
  PKC                                                            Gö6976 (1 µM)[2](#tf1-2){ref-type="table-fn"}                                               Partial                     Partial
  Rho                                                            C3 transferase[5](#tf1-5){ref-type="table-fn"}                                              \+                          \+
                                                                 shRNA[5](#tf1-5){ref-type="table-fn"}                                                       Partial                     --
  Rock                                                           Glycyl-H1152 (2 µM)[5](#tf1-5){ref-type="table-fn"}                                         \+                          Partial
  Cdc42                                                          Wasp (210--321)[5](#tf1-5){ref-type="table-fn"}                                             --                          Partial
                                                                 shRNA[5](#tf1-5){ref-type="table-fn"}                                                       --                          \+
  Pak                                                            IAP3 (100 µM)[5](#tf1-5){ref-type="table-fn"}                                               --                          \+
  Actin                                                          LatrunculinA (20nM)[1](#tf1-1){ref-type="table-fn"}                                         --                          Partial
                                                                 LatrunculinA (100-200nM)[1](#tf1-1){ref-type="table-fn"},[2](#tf1-2){ref-type="table-fn"}   \+                          \+
  Protein synthesis                                              Anisomycin (5--25 µM)[6](#tf1-6){ref-type="table-fn"}, [7](#tf1-7){ref-type="table-fn"}     --                          --
                                                                 Cyclohexiamide (300 µM)[6](#tf1-6){ref-type="table-fn"}, [7](#tf1-7){ref-type="table-fn"}   --                          --
  2-photon Glutamate uncaging paired with postsynaptic spiking                                                                                                                           
  TrkB                                                           K252a (200nM)[6](#tf1-6){ref-type="table-fn"}                                               --                          \+
                                                                 Anti-TrkB[6](#tf1-6){ref-type="table-fn"}                                                   --                          \+
                                                                 TrkB-Fc[6](#tf1-6){ref-type="table-fn"}                                                     --                          \+
  Protein synthesis                                              Anisomycin (5--25 µM)[6](#tf1-6){ref-type="table-fn"}                                       --                          \+
                                                                 Cyclohexiamide (300 µM)[6](#tf1-6){ref-type="table-fn"}                                     --                          \+
  Electric stimulation (Theta burst or 100 Hz Tetanus)                                                                                                                                   
  Exocytosis                                                     Botox[8](#tf1-8){ref-type="table-fn"}                                                       --                          \+
  PKA                                                            PKI[9](#tf1-9){ref-type="table-fn"}                                                         --                          \+
  Protein synthesis                                              Anisomycin (20 µM)[8](#tf1-8){ref-type="table-fn"}                                          --                          \+
                                                                 Cyclohexiamide (60 µM)[8](#tf1-8){ref-type="table-fn"}                                      --                          \+
  CaMKII                                                         CaMKII (K42R knock-in)[9](#tf1-9){ref-type="table-fn"}                                      --                          \+
  Chemical LTP                                                                                                                                                                           
  CaMKI                                                          STO-609 (10 µM)[10](#tf1-10){ref-type="table-fn"}                                           NA                          \+
                                                                 DN-CaMKI[10](#tf1-10){ref-type="table-fn"}                                                  NA                          \+
  Pak                                                            DN-PAK[10](#tf1-10){ref-type="table-fn"}                                                    NA                          \+
  Cofilin                                                        Cofilin S3A[11](#tf1-11){ref-type="table-fn"}                                               NA                          \+
  Exocytosis                                                     DN-Rab11 (S25N)[12](#tf1-12){ref-type="table-fn"}                                           NA                          \+
                                                                 DN-Rme1 (G429R)[12](#tf1-12){ref-type="table-fn"}                                           NA                          \+
  AMPAR insertion                                                GluA1 C-tail[13](#tf1-13){ref-type="table-fn"}                                              NA                          --

Drugs are listed with concentration in parentheses; mutants are listed in italics. **+**denotes blockade of structural plasticity by the manipulation; -- denotes no block. Stimulus protocols are as follows: Mg^2+^ free uncaging means glutamate uncaging on spines in ACSF lacking Mg^2+^, but including TTX. Theta burst stands for theta burst protocol stimulation of Schaffer Collaterals (see ([@b114]) for details). Spike pairing means pairing glutamate uncaging with spikes delivered via whole-cell patch clamp. Transient block refers to structural plasticity immediately following stimulation, while sustained block refers to structural plasticity \>20 min. after stimulation. Plus sign (+) indicates full inhibition (\>∼80%), minus sign (--) indicates no inhibition (\<∼20%) and 'Partial' indicates partial inhibition. Many experiments have been done using NMDAR antagonists; only two were listed here. NA: not applicable.
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Ras/ERK
-------

One of the many downstream pathways from CaMKII is the Ras--Raf--mitogen-activated protein kinase/ERK kinase (MEK)--ERK (Ras-Raf-MEK-ERK) signalling pathway ([Figure 1](#fig01){ref-type="fig"}). The Ras family of small GTPases is best known for its role in cancer ([@b94]). Small GTPases are activated by guanosine nucleotide exchange factors (GEFs) and inactivated by GTPase activation proteins (GAPs). Many GEFs and GAPs reside in or near the synapse and are activated during synaptic plasticity. For example, the GEF RasGRF1 is neuron specific and associates directly with the GluN2B subunit of NMDAR ([@b20]; [@b54]). For GAPs, SynGAP associates with PSD-95, resides in the postsynaptic density (PSD) and is phosphorylated by CaMKII, which decreases its activity ([@b15]; [@b50]). Ras has multiple downstream effectors, including Raf--MEK--ERK ([@b106]) and phophotydilinositol-3 kinase (PI3K) ([@b85]). ERK signalling has been shown to be required for LTP in Schaffer Collateral synapses and some forms of memory by pharmacological inhibition of MEK ([@b18]; [@b6]; [@b95]; [@b96]). Later, Ras was implicated in LTP: constitutively active and dominant negative Ras increased and decreased synaptic EPSCs respectively ([@b120]). These results similarly occluded and precluded LTP.

For structural plasticity, uncaging on spines in the presence of the MEK inhibitor U0126 blocked sustained structural plasticity without effecting the transient phase, in a similar manner to KN62\'s block of late, but not early, structural plasticity ([Figure 2](#fig02){ref-type="fig"}) ([@b32]; [@b84]). Overexpression of dn-Ras (Ras 17N) also blocked sustained but not transient structural plasticity. These results suggest that the Ras--ERK pathway is important for spine structural plasticity as well as LTP. Finally, inhibitors of CaMKs (KN62) and ERK (U0126) show additive effects ([@b32]): when either one of them is used, the sustained phase of structural plasticity is inhibited only partially (∼50%), while when added together, it completely inhibits structural plasticity ([Figure 2C](#fig02){ref-type="fig"}), suggesting that CaMK and ERK are in parallel pathways.

Rho GTPases
-----------

Rho GTPases, including Rac1, Cdc42 and RhoA, regulate actin organization ([@b39]) and play important roles in regulating spine morphology ([@b67]; [@b105]; [@b90]) and function ([@b110]; [@b5]; [@b86]; [@b29]; [@b74]). Recently, the involvement of Rho GTPase proteins Rho and Cdc42 in glutamate uncaging-induced spine enlargement has been studied ([@b77]). When Cdc42 signalling is inhibited by expressing shRNA against Cdc42 or the Cdc42 binding domain of Wasp \[Wasp(210--321)\], sustained spine growth is inhibited, while the transient phase remains intact. Furthermore, inhibition of Pak, one of Cdc42\'s downstream effectors, by IAP3 showed a similar phenotype, suggesting that the Cdc42--Pak pathway is important for maintenance of the sustained spine growth. Also, when Rho signalling is inhibited by expressing shRNA against Rho, the transient phase is preferentially inhibited. Stronger inhibition of Rho by C3 transferase, as well as pharmacological inhibition of downstream factor Rock (Glycyl-H1152), inhibited both transient and sustained phases of the spine growth, suggesting that the Rho--Rock pathway is important for both transient and sustained spine growth.

PI3K
----

PI3Ks are a class of phosphatidylinositol kinases that add a phosphate group to phosphatidylinositol (4,5)-triphosphate (PIP~2~), creating phosphatidylinositol (3,4,5)-triphosphate (PIP~3~) ([@b33]). Ras, besides activating the Raf--MEK--ERK pathway, can activate PI3K and the synthesis of PIP~3~ ([@b85]). PIP~3~ associates with many proteins that contain pleckstrin-homology (PH) domains specific to PIP~3~, including downstream Akt ([@b8]). While phosphoinositides are well known for their role in membrane trafficking and neurite growth, PI3K and PIP~3~\'s roles in LTP were more recently discovered. This was first shown when the application of the PI3K antagonist wortmannin blocked perforant path LTP *in vivo* in rats by a presynaptic mechanism ([@b46]). PI3K\'s role in Schaffer Collateral LTP was shown soon after, as both wortmannin and LY294002 were able to block LTP if applied during LTP induction ([@b92]; [@b79]; [@b85]). Antagonists applied during the maintenance phase were able to reduce LTP but only if applied at higher doses than necessary to block LTP induction (wortmannin: 200 nM vs. 5 µM; LY294002: 20 µM vs. 100 µM) ([@b92]; [@b79]). These higher doses of antagonists also caused a rundown in basal EPSC of the unstimulated pathway ([@b79]; [@b43]). Finally, transfecting neurons with PH domains of general receptor for phosphoinositides (GRP), which binds to and thus masks PIP~3~, blocks LTP ([@b4]).

As for spine structural plasticity, the PI3K inhibitor LY294002 effects neither transient nor sustained structural plasticity ([Table 1](#tbl1){ref-type="table"}, [Figure 3B](#fig03){ref-type="fig"}) ([@b32]). However, this could be due to relatively low dose (20 µM) used in the studies. A higher dose (100 µM) of LY294002 can inhibit the sustained phase of structural plasticity (Patterson and Yasuda, unpubl. data).

![Pharmacology of spine Ras activation. A. Representative fluorescence lifetime images of Ras activation. B. Time course of average Ras activation in the spine. Ras activation was blocked by CPP (NMDAR inhibitor) and LY294002 (PI3K inhibitor). C. Pharmacology of Ras activation. For signalling molecules each inhibitor affects, please refer to [Table 1](#tbl1){ref-type="table"}. All panels adapted from ([@b32]).](bph0163-1626-f3){#fig03}

PKC
---

PKC was one of the first kinases to be implicated in LTP when it was found that intracellular injection of PKC into a CA1 neuron increased its EPSP and lowered its firing threshold ([@b40]). A series of papers then followed using a variety of non-specific PKC antagonists including K-252b, mellitin, PMB and H-7, which showed that these antagonists could block the induction of LTP in the Schaffer Collateral as well as the perforant path ([@b65]; [@b87]; [@b71]). The PKC specificity of these drugs were confirmed using the peptide inhibitor PKC(19--31) ([@b71]; [@b108]; [@b109]). PKC inhibitors could effectively reduce LTP when applied up to 3 h later ([@b65]; [@b108]). Several isoforms have been implicated in the induction and maintenance of LTP ([@b1]). One isoform in particular, the atypical, constitutively active isoform PKMζ has been found to be important specifically for the maintenance of LTP ([@b61]) as well as some forms of memory ([@b97]).

In contrast to the intense study of PKC in LTP, much less is known about PKC\'s role in spine structural plasticity. Application of Gö6976, the inhibitor of Ca^2+^-dependent PKCα and β, impaired both transient and sustained phases of structural plasticity partially ([@b32]).

Other kinases
-------------

CaMKI is activated by CaMK kinase and Ca^2+^/calmodulin ([@b111]). It has been shown to be required for ERK activation and LTP by using specific inhibitor STO-609 ([@b93]). Also, during chemical LTP, CaMKI signals to Pak, leading to spine enlargement ([@b21]).

Actin
-----

In addition to the second messengers above, a variety of cellular processes have been investigated pharmacologically, foremost among them actin polymerization. Dendritic spines contain high concentrations of actin, of which 80--90% are filamentous (F-actin) ([@b98]). The regulation of the actin cytoskeleton is important for spine morphology: actin polymerization and depolymerization are associated with spine enlargement and shrinkage during LTP and LTD respectively ([@b22]; [@b78]). Furthermore, spine enlargement during LTP is inhibited by the inhibitor of action polymerization latrunculin A (LatA) in a dosage-dependent manner: at low doses (20 nM), it inhibits only the sustained phase ([@b73]), while at higher doses (100--200 nM), LatA inhibits both the transient and sustained phases of structural plasticity ([@b73]; [@b32]); at an extremely high dose (10 µM), LatA causes spine shrinkage ([@b37]; [@b76]). These are consistent with the finding that multiple forms of F-actin assembly exist in dendritic spines ([@b37]).

Importantly, pharmacological inhibition of actin polymerization with latrunculin A/B or cytochalasin D inhibits LTP ([@b51]; [@b22]) as well as spine structural plasticity ([@b73]). Also, many signalling proteins that regulate actin organization including the Rho GTPase proteins, Pak, Rho kinase (Rock) and Cofilin have been found to be required for inducing LTP ([@b110]; [@b5]; [@b86]; [@b29]; [@b74]). Thus, unlike LTD, from which spine shrinkage can be dissociated ([@b119]), LTP seems to be more tightly coupled with spine enlargement ([@b44]).

Membrane and vesicular trafficking
----------------------------------

One of the critical output steps of synaptic plasticity is the fusion of recycling endosomes with the plasma membrane, and the exocytosis of membrane proteins including AMPARs. Blockade of exocytosis by tetanus toxin or Botox almost completely blocks LTP and structural plasticity ([@b66]; [@b114]). Membrane trafficking between the plasma membrane and recycling endosomes is regulated by a variety of SNAREs (soluble N-ethylmaleimide sensitive fusion protein attachment protein receptors), GTPases and other proteins that confer target specificity and regulate membrane fusion. Of the SNAREs, two have been identified as important for plasticity: syntaxin 13, which directs traffic from early endosomes to the recycling endosome, and syntaxin 4, which is involved in exocytosis at the plasma membrane. Soluble forms of either syntaxin 4 or 13 \[produced by the removal of their transmembrane (TM) domains; Syn13ΔTM and Syn4ΔTM\], which block membrane fusion, impair AMPAR exocytosis, structural plasticity and LTP ([Table 1](#tbl1){ref-type="table"}) ([@b82]; [@b83]; [@b48]). Dominant-negative mutants of proteins required for endosome trafficking, Rab11a (S25N) and the Eps15 homology domain/receptor-mediated endocytosis-1 \[Rme1 (G249R)\], also block AMPAR exocytosis, structural plasticity, and LTP ([@b82]; [@b83];).

In addition to moving proteins to the plasma membrane, it has been hypothesized that exocytosis in the spine could provide additional membrane to aid spine expansion. The total membrane of endosomes in the spine, as measured by electron micrograph, is roughly half that of the spine itself ([@b83]). Simultaneous measurement of spine size and AMPAR exocytosis had been roughly measured on the time scale of minutes with inconclusive results ([@b52]; [@b83]). More recently, we measured individual exocytosis events in spines and correlated this with changes in spine size within 10 s of the exocytosis event and found that spine size increases simultaneously with exocytosis ([@b84]). This lends credence to the idea that endosomal fusion can provide membrane to the spine.

Protein synthesis
-----------------

LTP is often delineated into two types: early LTP (E-LTP), which lasts for 1--2 h and is independent of protein synthesis; and late LTP (L-LTP), which persists longer, requires repeated stimuli and is protein synthesis dependent. The role of protein synthesis has been reviewed extensively elsewhere ([@b45]; [@b100]), but the gist of the research is that application of protein synthesis inhibitors (typically anisomycin or cyclohexamide) during induction can block LTP.

This work has been recently ported to imaging of structural plasticity. One group used a theta-burst stimulation protocol to induce plasticity and measured structural plasticity at many spines ([@b114]). They found that normally there is a persistent increase in spine size, but this increase was blocked by application of either anisomycin, or cyclohexamide. Tanaka *et al*. developed a modified pairing protocol, wherein they patched onto a cell and injected current pulses through the pipette to elicit back-propagating action potentials ∼20 ms after each uncaging pulse, in the presence of Mg^2+^ ([@b104]). This 'uncaging-with-spikes' protocol yielded a transient increase in spine size and uncaging EPSC that increased over the next hour ([Table 1](#tbl1){ref-type="table"}). In contrast, unpaired uncaging yielded a more typical time course with a peak followed by a plateau (e.g. [Figure 2B](#fig02){ref-type="fig"}). Tanaka *et al*. tested the protein synthesis dependence of structural plasticity and found that applying anisomycin blocked the gradual plasticity found following 'uncaging with spikes' but did not affect the unpaired uncaging results. They further showed that the 'uncaging with spikes' protocol was dependent on brain-derived neurotrophic factor (BDNF)-tyrosine kinase receptor B (TrkB) signalling ([Table 1](#tbl1){ref-type="table"}). Finally, it has been reported that bath application of BDNF or forskolin during glutamate uncaging is sufficient to induce protein synthesis--dependent spine enlargement ([@b104]; [@b27]). These results show that protein synthesis is essential for some forms of structural plasticity.

Monitoring signal transduction in single spines
===============================================

Moving beyond simply measuring structural plasticity, fluorescent sensors -- specifically FRET sensors -- enable one to measure the activity of signalling molecules directly. These sensors have been optimized for imaging single spines by using two-photon fluorescence lifetime imaging microscopy (2pFLIM) ([@b115]; [@b116]). Using 2pFLIM, the activities of CaMKII, Ras, Cdc42 and RhoA have been imaged.

2pFLIM
------

Intracellular signal transduction has been visualized using FRET-based signalling sensors. FRET is the process of energy transfer from an excited donor fluorophore to an acceptor fluorophore via dipole--dipole interaction ([@b55]). Because FRET strongly depends on the distance between donor and acceptor and occurs only on the nanometer scale, FRET can be used to monitor protein--protein interactions for proteins fused to fluorophores or conformation changes of a protein tagged with two fluorophores. The fluorescence lifetime of the donor, which is the time between the excitation of the fluorophore and emission of a photon, shortens as FRET increases and thus can be used to measure FRET with high sensitivity independent of the relative concentration of donor and acceptor ([@b55]). 2pFLIM, which combines two-photon microscopy with fluorescence lifetime measurement, allows one to quantitatively image FRET signal from the tiny volume of spines in light-scattering brain slices ([@b102]; [@b115]). Several sensors designed specifically for 2pFLIM have been developed and used for imaging signal transduction in single dendritic spines ([@b116]; [@b32]; [@b56]; [@b77]).

While FRET imaging is the only method to access intracellular signalling in individual spines, because FRET imaging relies on overexpressed sensor, one must evaluate the effects of overexpression on the spatiotemporal dynamics of signalling by measuring the relationship between the concentration of the sensor (measured from the brightness) and the spatiotemporal parameters of signalling (e.g. decay time constant, length constant) ([@b32]; [@b56]). Also, the degree of signal perturbation needs to be evaluated ([@b32]; [@b56]).

CaMKII
------

The dynamics of CaMKII signalling have been measured using biochemical methods, and it was proposed that CaMKII signals last for hours, due to Ca^2+^-independent, 'autonomous' activity produced by the autophoshorylation at T286, to maintain synaptic plasticity ([@b24]; [@b23]; [@b7]; [@b57]). However, inhibition of CaMKII after establishing LTP using various types of inhibitors does not affect the maintenance of LTP ([@b71]; [@b80]; [@b14]; [@b11]) (but see [@b91]). Furthermore, [@b57] reported that T286 phosphorylation persists long term, while autonomous activity decays within ∼2 min during LTP.

The dynamics of CaMKII activity in neurons have been measured by a FRET sensor, Camui-α ([@b103]; [@b56]). Camui-α is a single CaMKIIα molecule tagged with a donor--acceptor fluorescent pair such as ECFP--Venus at each end. Inactive CaMKII subunits rest in a closed configuration ([@b88]; [@b13]), causing FRET between the donor and acceptor at its ends; when activated, CaMKII subunits open ([@b88]; [@b13]), separating the fluorophores and decreasing FRET.

In order to image CaMKII activity in single dendritic spines in cultured hippocampal slices, [@b56] applied 2pFLIM and optimized Camui-α for 2pFLIM. The resulting sensor, named Green Camui-α, in which the monomeric EGFP--resonance energy transfer acceptor chromophore (REACh) FRET pair ([@b25]; [@b76]) is used instead of ECFP--Venus pair, showed high sensitivity sufficient for single spine imaging under 2pFLIM ([@b56]).

In response to two-photon glutamate uncaging, CaMKII activity increased in the stimulated spines rapidly, and decayed within 1 min. The detailed analyses showed that the decay time constant of CaMKII is ∼6 s. The role of T286 phosphorylation was also demonstrated using a Green Camui-α mutant deficient in autophosphorylation at T286 \[Green Camui-α with CaMKIIα(T286A)\]. The mutant Green Camui-α displayed fast inactivation (\<2 s), and because of the fast inactivation, the repetitive uncaging activation did not accumulate. This study suggests that CaMKII autophosphorylation is a biochemical memory on the time scale of seconds, but not hours, and helps integrate short Ca^2+^ signals.

Ras
---

### Pharmacology of Ras activation in single spine

Like CaMKII, there is a fluorescent sensor for Ras activity optimized for 2pFLIM and single spine imaging. The intermolecular FRET sensor FRas consists of two molecules: mEGFP tagged H-Ras (GFP-Ras) and the Ras binding domain (RBD) of Raf1 tagged with mRFP (RFP-RBD) ([@b116]). When Ras is inactive, these two molecules do not interact. However, when GFP-Ras binds GTP, it binds to RFP-RBD, causing FRET. To test Ras\'s role in synaptic plasticity, this sensor was transfected into CA1 pyramidal neurons, and glutamate uncaging was performed.

Uncaging on spines activated Ras in the stimulated spine within 1 min, and this activation decayed with a time constant of ∼4--5 min ([@b32]). Unlike CaMKII, active Ras was not restricted to the stimulated spine and diffused into the dendrite over ∼10 µm and even into adjacent spines.

Harvey *et al*. investigated the signalling pathways underlying Ras activation by combining Ras imaging with pharmacology. Ras activation was sensitive to inhibitors of CaMKII (KN62), PI3K (LY294002) and PKC (Gö6976), which caused a ∼ 30%, 60% and 40% reduction in Ras activation respectively ([Figure 3](#fig03){ref-type="fig"}). Of these, the PI3K inhibitor\'s effect is most interesting, as PI3K is a known effector of Ras, which implies that there may be a functional Ras-PI3K feedback loop in neurons ([@b12]) ([Figure 1](#fig01){ref-type="fig"}).

### AMPAR exocytosis is regulated by Ras

One of the goals of using fluorescent sensors for signalling activity is to be able to connect specific cellular outcomes with particular signalling pathways. Recently, an assay for imaging AMPAR exocytosis using pHluorin-tagged GluA1 (SEP-GluA1) has been developed ([@b60]; [@b118]). pHluorins are pH-sensitive fluorophores that are only fluorescent at high pHs (\>7), like the pH of ACSF ([@b75]). Given that the pH of endosomes is typically 5--6, SEP-GluA1 selectively labels surface AMPAR ([@b52]). Following the bleaching of all surface receptors, it is possible to image changes in fluorescence due to AMPAR exocytosis ([@b60]; [@b118]).

Combining SEP-GluA1 with glutamate uncaging, it is possible to determine the spatial profile of AMPAR exocytosis during LTP and structural plasticity induced in single spines ([@b69]; [@b84]). Using this method, it has been found that AMPAR are exocytosed in the stimulated spine ([@b84]) and in the parent dendrite within ∼3 µm ([@b69]; [@b84]), just as Ras activity spreads into the dendrite ([@b32]). Consistent with this spatial profile, activity-dependent AMPAR exocytosis was inhibited by inhibition of the Ras--ERK pathway by applying ERK inhibitor U0126 or expressing dominant-negative Ras mutant, but not by inhibition of CaMK with KN62 ([@b84]). Thus, these studies linked a specific sub-step of LTP (and potentially structural plasticity), AMPAR exocytosis, to Ras signalling ([Figure 1](#fig01){ref-type="fig"}).

Rho-GTPases
-----------

Rho GTPases are a subfamily of the Ras superfamily of proteins. Because they share structural and biochemical properties with Ras, it is possible to use similar sensors for these molecules. [@b77] recently developed sensitive sensors for two Rho proteins, RhoA and Cdc42, and measured their activity in spines during structural plasticity. Induction of spine growth caused rapid Cdc42 and RhoA activation that persisted more than ∼30 min in the stimulated spine. Notably, RhoA and Cdc42 showed contrasting activity patterns: RhoA activity spread over several microns along the dendrite, while Cdc42 activity was restricted to the stimulated spine. Inhibition of CaMKII using KN62 or autocamtide CaMKII inhibitor peptide 2 (AIP2) inhibited the activity of Cdc42 and RhoA partially, suggesting these molecules are downstream of CaMKII ([Figure 1](#fig01){ref-type="fig"}) ([@b77]).

Conclusion
==========

While the use of imaging technology to measure LTP/LTD and associated spine structural plasticity is barely a decade old, it has provided new insights into the signalling mechanisms coupling Ca^2+^ to the structure and function of dendritic spines. These studies have revealed a complicated signalling network triggering the induction of LTP and spine structural plasticity ([Figure 1](#fig01){ref-type="fig"}). Both structural and functional plasticity require similar signalling networks and signal via the mechanisms of actin polymerization as well as the supply of receptors and membrane from the exocytosis of endosomes ([Figure 1](#fig01){ref-type="fig"}). Although these pathways are found in experiments performed in slices or primary dissociated neurons, similar pathways may also be used in *in vivo* spine structural plasticity induced by experience or drug abuse ([@b36]; [@b89]).

Besides using imaging to measure plasticity, the development of fluorescent sensors for signalling molecules has allowed scientists to directly measure signalling activity. Using these sensors, we have found that different signalling molecules have strikingly different spatiotemporal profiles. Inactivation time constants can range from 6 s (CaMKII) to 5 min (Ras) to ∼30 min (RhoA, Cdc42), and perhaps even longer. Some molecules are activated exclusively in the stimulated spine (CaMKII, Cdc42), while others are activated in the spine before diffusing into the dendrite and neighbouring spines (Ras, RhoA). The use of antagonists in combination with these sensors will allow more direct testing of signalling interactions; one example are PI3K antagonists effects on Ras activity ([Figure 1](#fig01){ref-type="fig"}).

Besides creating opportunities to monitor signalling pathways, in the future optical techniques will provide new opportunities to manipulate them. Photoactivatable proteins for an adrenergic receptor ([@b2]), Rho-family GTPases ([@b59]; [@b112]; [@b117]) and WASP ([@b58]) have all been recently developed, each of which work by different methods. These tools will allow researchers to precisely manipulate the function of molecules in real time. As more imaging tools are developed, we will hopefully be able to disentangle the complicated signalling responsible for LTP and ultimately memory.
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:   2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid
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GEF
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:   postsynaptic density
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